On July 23, Molina Healthcare declined 7.1% overnight, trading at $206.0 per share, with turnover of $2,882.98.

On the news front, the company reported Q2 adjusted EPS of $1.51, beating the consensus estimate of $1.39 but plunging 72.45% from $5.48 a year earlier. Revenue fell to $10.87 billion from $11.43 billion year-over-year, slightly exceeding the $10.83 billion estimate. While the company raised its full-year adjusted EPS outlook to at least $5.25 from the prior $5.00 guidance, it disclosed that legacy MAPD products are expected to generate a $1.00 per share loss drag. Additionally, the implementation of a new Florida Medicaid contract in Q4 is projected to add approximately $1.50 per share in losses to full-year results. Despite the quarterly beat, the severe year-over-year earnings deterioration combined with multiple business headwinds pressured market sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)